125535 (2027)

: The study uses "exogenous" (externally introduced) sickle red blood cells in combination with a vascular-disrupting agent to target the blood supply of tumors.

: The treatment demonstrated significant effectiveness in causing lung tumor regression in experimental models. 125535

: "The impact of public eco-concern on urban eco-efficiency: A dual perspective analysis of net effect and configuration." Authors : Chao Wang and Jinbo Jiang. : The study uses "exogenous" (externally introduced) sickle

: This highlights a potential "therapeutic repurposing" of sickle cell biology to combat cancer by starving tumors of their oxygen and nutrient supply. Alternative Reference 125535

The number primarily refers to a medical research paper titled "Exogenous sickle erythrocytes combined with vascular disruption trigger disseminated tumor vaso-occlusion and lung tumor regression" . Article Overview: JCI Insight 125535